Literature DB >> 27795377

Molecular Bases Determining Daptomycin Resistance-Mediated Resensitization to β-Lactams (Seesaw Effect) in Methicillin-Resistant Staphylococcus aureus.

Adriana Renzoni1, William L Kelley2, Roberto R Rosato3, Maria P Martinez3, Melanie Roch3, Maryam Fatouraei3, Daniel P Haeusser4, William Margolin4, Samuel Fenn5, Robert D Turner5, Simon J Foster5, Adriana E Rosato6.   

Abstract

Antimicrobial resistance is recognized as one of the principal threats to public health worldwide, yet the problem is increasing. Infections caused by methicillin-resistant Staphylococcus aureus (MRSA) strains are among the most difficult to treat in clinical settings due to the resistance of MRSA to nearly all available antibiotics. The cyclic anionic lipopeptide antibiotic daptomycin (DAP) is the clinical mainstay of anti-MRSA therapy. The decreased susceptibility to DAP (DAP resistance [DAPr]) reported in MRSA is frequently accompanied by a paradoxical decrease in β-lactam resistance, a process known as the "seesaw effect." Despite the observed discordance in resistance phenotypes, the combination of DAP and β-lactams has been proven to be clinically effective for the prevention and treatment of infections due to DAPr MRSA strains. However, the mechanisms underlying the interactions between DAP and β-lactams are largely unknown. In the study described here, we studied the role of mprF with DAP-induced mutations in β-lactam sensitization and its involvement in the effective killing by the DAP-oxacillin (OXA) combination. DAP-OXA-mediated effects resulted in cell wall perturbations, including changes in peptidoglycan insertion, penicillin-binding protein 2 (PBP 2) delocalization, and reduced membrane amounts of PBP 2a, despite the increased transcription of mecA through mec regulatory elements. We have found that the VraSR sensor-regulator is a key component of DAP resistance, triggering mutated mprF-mediated cell membrane (CM) modifications that result in impairment of PrsA location and chaperone functions, both of which are essential for PBP 2a maturation, the key determinant of β-lactam resistance. These observations provide for the first time evidence that synergistic effects between DAP and β-lactams involve PrsA posttranscriptional regulation of CM-associated PBP 2a.
Copyright © 2016 American Society for Microbiology.

Entities:  

Keywords:  MRSA; PrsA; daptomycin; seesaw effect; β-lactams

Mesh:

Substances:

Year:  2016        PMID: 27795377      PMCID: PMC5192149          DOI: 10.1128/AAC.01634-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  48 in total

Review 1.  Stimulus perception in bacterial signal-transducing histidine kinases.

Authors:  Thorsten Mascher; John D Helmann; Gottfried Unden
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

2.  Peptidoglycan composition of a highly methicillin-resistant Staphylococcus aureus strain. The role of penicillin binding protein 2A.

Authors:  B L de Jonge; Y S Chang; D Gage; A Tomasz
Journal:  J Biol Chem       Date:  1992-06-05       Impact factor: 5.157

3.  Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding.

Authors:  Abhay Dhand; Arnold S Bayer; Joseph Pogliano; Soo-Jin Yang; Michael Bolaris; Victor Nizet; Guiquing Wang; George Sakoulas
Journal:  Clin Infect Dis       Date:  2011-07-15       Impact factor: 9.079

4.  Evolution of a vancomycin-intermediate Staphylococcus aureus strain in vivo: multiple changes in the antibiotic resistance phenotypes of a single lineage of methicillin-resistant S. aureus under the impact of antibiotics administered for chemotherapy.

Authors:  K Sieradzki; T Leski; J Dick; L Borio; A Tomasz
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

5.  Penicillin-binding protein 2 is essential for expression of high-level vancomycin resistance and cell wall synthesis in vancomycin-resistant Staphylococcus aureus carrying the enterococcal vanA gene complex.

Authors:  Anatoly Severin; Shang Wei Wu; Keiko Tabei; Alexander Tomasz
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

6.  Lipid modification of bacterial prolipoprotein. Transfer of diacylglyceryl moiety from phosphatidylglycerol.

Authors:  K Sankaran; H C Wu
Journal:  J Biol Chem       Date:  1994-08-05       Impact factor: 5.157

7.  Enterococcus faecalis constitutes an unusual bacterial model in lysozyme resistance.

Authors:  Laurent Hébert; Pascal Courtin; Riccardo Torelli; Maurizio Sanguinetti; Marie-Pierre Chapot-Chartier; Yanick Auffray; Abdellah Benachour
Journal:  Infect Immun       Date:  2007-09-04       Impact factor: 3.441

8.  Comparative pharmacodynamics of meropenem using an in-vitro model to simulate once, twice and three times daily dosing in humans.

Authors:  K E Bowker; H A Holt; R J Lewis; D S Reeves; A P MacGowan
Journal:  J Antimicrob Chemother       Date:  1998-10       Impact factor: 5.790

9.  Staphylococcus aureus Survives with a Minimal Peptidoglycan Synthesis Machine but Sacrifices Virulence and Antibiotic Resistance.

Authors:  Patricia Reed; Magda L Atilano; Renato Alves; Egbert Hoiczyk; Xinwei Sher; Nathalie T Reichmann; Pedro M Pereira; Terry Roemer; Sérgio R Filipe; José B Pereira-Leal; Petros Ligoxygakis; Mariana G Pinho
Journal:  PLoS Pathog       Date:  2015-05-07       Impact factor: 6.823

10.  A variable DNA recognition site organization establishes the LiaR-mediated cell envelope stress response of enterococci to daptomycin.

Authors:  Milya Davlieva; Yiwen Shi; Paul G Leonard; Troy A Johnson; Michael R Zianni; Cesar A Arias; John E Ladbury; Yousif Shamoo
Journal:  Nucleic Acids Res       Date:  2015-04-19       Impact factor: 16.971

View more
  30 in total

1.  Prolonged Exposure to β-Lactam Antibiotics Reestablishes Susceptibility of Daptomycin-Nonsusceptible Staphylococcus aureus to Daptomycin.

Authors:  Rachel E Jenson; Sarah L Baines; Benjamin P Howden; Nagendra N Mishra; Sabrina Farah; Cassandra Lew; Andrew D Berti; Sanjay K Shukla; Arnold S Bayer; Warren E Rose
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

2.  Dalbavancin Alone and in Combination with Ceftaroline against Four Different Phenotypes of Staphylococcus aureus in a Simulated Pharmacodynamic/Pharmacokinetic Model.

Authors:  Razieh Kebriaei; Seth A Rice; Kyle C Stamper; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

3.  Occurrence of cross-resistance and β-lactam seesaw effect in glycopeptide-, lipopeptide- and lipoglycopeptide-resistant MRSA correlates with membrane phosphatidylglycerol levels.

Authors:  Kelly M Hines; Tianwei Shen; Nathaniel K Ashford; Adam Waalkes; Kelsi Penewit; Elizabeth A Holmes; Kathryn McLean; Stephen J Salipante; Brian J Werth; Libin Xu
Journal:  J Antimicrob Chemother       Date:  2020-05-01       Impact factor: 5.790

4.  Distinct Subpopulations of Intravalvular Methicillin-Resistant Staphylococcus aureus with Variable Susceptibility to Daptomycin in Tricuspid Valve Endocarditis.

Authors:  Christopher R Miller; Somrita Dey; Paula D Smolenski; Pushkar S Kulkarni; Jonathan M Monk; Richard Szubin; George Sakoulas; Andrew D Berti
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

5.  Impact of PrsA on membrane lipid composition during daptomycin-resistance-mediated β-lactam sensitization in clinical MRSA strains.

Authors:  Carla C C R de Carvalho; Agustina Taglialegna; Adriana E Rosato
Journal:  J Antimicrob Chemother       Date:  2021-12-24       Impact factor: 5.758

6.  The Role of mprF Mutations in Seesaw Effect of Daptomycin-Resistant Methicillin-Resistant Staphylococcus aureus Isolates.

Authors:  Shengnan Jiang; Hemu Zhuang; Feiteng Zhu; Xiang Wei; Junxiong Zhang; Lu Sun; Shujuan Ji; Haiping Wang; Dandan Wu; Feng Zhao; Rushuang Yan; Yunsong Yu; Yan Chen
Journal:  Antimicrob Agents Chemother       Date:  2021-10-18       Impact factor: 5.938

7.  The Combination of Daptomycin and Fosfomycin Has Synergistic, Potent, and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus in a Rabbit Model of Experimental Endocarditis.

Authors:  Cristina García-de-la-Mària; Oriol Gasch; Javier García-Gonzalez; Dolors Soy; Evelyn Shaw; Juan Ambrosioni; Manel Almela; Juan M Pericàs; Adrián Tellez; Carlos Falces; Marta Hernandez-Meneses; Elena Sandoval; Eduard Quintana; Barbara Vidal; Jose M Tolosana; David Fuster; Jaume Llopis; Miquel Pujol; Asuncion Moreno; Francesc Marco; Jose M Miró
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

8.  Case Commentary: Delayed Cerebral Vasculitis Associated with the Development of Ceftriaxone-Resistant Pneumococcal Meningitis.

Authors:  Rodrigo Hasbun
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

Review 9.  Current Paradigms of Combination Therapy in Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: Does it Work, Which Combination, and For Which Patients?

Authors:  Warren Rose; Michael Fantl; Matthew Geriak; Victor Nizet; George Sakoulas
Journal:  Clin Infect Dis       Date:  2021-12-16       Impact factor: 9.079

10.  β-Lactam-Induced Cell Envelope Adaptations, Not Solely Enhanced Daptomycin Binding, Underlie Daptomycin-β-Lactam Synergy in Methicillin-Resistant Staphylococcus aureus.

Authors:  Cassandra Lew; Nagendra N Mishra; Arnold S Bayer; Warren E Rose
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.